News

Researchers used genomic sequencing to gain insights into how somatic mutations build up in normal cells before the onset of cancer, a process that is poorly understood.

Current methods for producing nanofibers are incredibly costly and therefore limit accessibility, this new study opens the door to cheap, mass produced nanofibers.

Triptorelin 6-month formulation phase III trial demonstrates good efficacy in terms of pituitary and gonadal suppression and in arresting or reversing progression of clinical signs of puberty and slowing down of accelerated bone maturation in children with CPP.

Scientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with “molecular fingerprints” which could pave the way for the rapid detection of conditions such as leukaemia and lymphoma from a small blood sample.

Many affected individuals still suffer with progressive joint damage, despite treatment. This study has discovered a new treatment target which could open a door to preventing this ongoing damage.

DIN EN ISO/IEC 17025:2005 accreditation to analyze RNA-based biomarkers from body fluids.

The grant awarded is to aid the development of a multi-site pelvic mass registry.

NIH-funded study provides new platform for testing treatments for several neurodegenerative disorders.

Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.

Research collaboration to investigate Nanobodies® against a target that plays an important role in multiple sclerosis.